Source: Healio Coverage
September 09, 2021
1 min read

Top in hem/onc: Antibiotics and cancer risk, physician burnout

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

A nationwide, population-based study revealed a consistent link between the use of antibiotics and proximal colon cancer. It was the top story in hematology/oncology last week.

Another top story included tips for combating burnout while still meeting demands as a physician.

Image of burnout
Source: Adobe Stock

Read these and more top stories in hematology/oncology below:

Use of antibiotics linked to increased risk for proximal colon cancer

Use of antibiotics appeared to be consistently associated with a higher subsequent risk for proximal colon cancer, according to data published in Journal of the National Cancer Institute. Read more.

Maintaining wellness as an oncologist: Balancing self-care, recognizing distractions

A physician’s job is never done, but for three oncologists, incorporating health, nutrition and mindfulness into their daily lives is vital to maintaining a sense of wellness and being fully present whether at home or work. Read more.

Cancer radiation treatment at high-volume centers associated with improved survival

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer. Read more.

Multicancer screening tests: Not ready for prime time

Scientists have made amazing advances in recent years in understanding the molecular biology of cancer. Despite these advances, a simple blood test to screen patients for early detection of cancer is not yet an approved option. Read more.

UCLA researchers receive $1 million to develop novel CAR T-cell therapies for melanoma

Cristina Puig-Saus, PhD, and Daniel S. Shin, MD, PhD, of UCLA Jonsson Comprehensive Cancer Center received a $1 million award from the U.S. Department of Defense for research into novel cell therapies for rare melanomas. Read more.